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All herpesviruses encode a homolog of glycoprotein M (gM), which appears to function in virion morpho-
genesis. Despite its conservation, gM is inessential for the lytic replication of alphaherpesviruses. In order to
address the importance of gM in gammaherpesviruses, we disrupted it in the murine gammaherpesvirus 68
(MHV-68). The mutant virus completely failed to propagate in normally permissive fibroblasts. The defective
genome was rescued by either homologous recombination to restore the wild-type gM in situ or the insertion
of an ectopic, intergenic expression cassette encoding gM into the viral genome. Thus, gM was essential for the
lytic replication of MHV-68.
All mammalian and avian herpesviruses encode conserved
glycoproteins—glycoprotein B (gB), gH, gL, gM, and gN—that
mediate the assembly of infectious virions, their exit from the
cell, and their subsequent fusion with new cellular membranes.
The functions of these glycoproteins are relatively well char-
acterized for the alphaherpesviruses and appear to be qualita-
tively similar in the beta- and gammaherpesviruses. However,
the quantitative contribution each glycoprotein makes to lytic
replication in alpha-, beta-, and gammaherpesviruses is not
necessarily the same. gM, which forms a complex with gN (14,
17, 18, 20, 29), is one of the most highly conserved of all
herpesvirus glycoproteins and has been retained in a recogniz-
able form over hundreds of millions of years of viral evolution.
Outside the context of viral infection, alphaherpesvirus gM/gN
complexes inhibit membrane fusion by a variety of endog-
enously synthesized proteins, including those of unrelated vi-
ruses (15; C. Crump, personal communication). The Kaposi’s
sarcoma-associated herpesvirus (KSHV) gM/gN complex has a
similar function (17). In infected cells, the pseudorabies virus
gM probably has a role in secondary envelopment, since a
gM/gE/gI triple mutant has a defect in cytoplasmic virion as-
sembly that is not seen with a gE/gI double mutant (4). How-
ever, disrupting gM alone has little effect on viral replication
(8). Even a gM/gE double knockout of herpes simplex virus
grows fairly normally in vitro (5). There may therefore be
considerable functional redundancy in the alphaherpesviruses
between gM, gE, gI, and gD (4, 10).
gM is probably an essential component of betaherpesviruses,
since in random mutagenesis libraries, transposon insertion
into the gM open reading frame (ORF) correlates with viral
nonviability (12, 30). However, this phenotype remains to be
formally linked to gM function by either viral reversion or
complementation.
No gammaherpesvirus gM mutant has been described pre-
viously. Indeed, although much is known about cell binding by
glycoproteins on gammaherpesvirus virions (2, 13), relatively
little is known about the contribution of viral glycoproteins to
other aspects of lytic propagation. This reflects the relative
difficulty of manipulating the lytic cycle of the Epstein-Barr
virus (EBV) and KSHV and of generating and analyzing tar-
geted gene knockouts. EBV lacking gN shows substantial, al-
though not complete, impairment of secondary virion envel-
opment and egress (19). As the EBV gM is unstable in the
absence of gN (18), the gN-deficient phenotype may reflect a
partial gM deficiency rather than a lack of gN itself; the con-
tribution of gM instability to the gN-deficient phenotype and
the consequences of a complete lack of gM in EBV have yet to
be defined.
In contrast to EBV and KSHV, a related murid gammaher-
pesvirus, MHV-68, readily enters the lytic replication cycle in
vitro. It therefore offers an opportunity to address fundamental
questions about the function of shared gammaherpesvirus gly-
coproteins in a more tractable experimental setting. We are
using MHV-68 to define the minimum set of glycoproteins
required for gammaherpesvirus lytic replication in vitro and in
vivo. The ultimate aim is to understand the mechanisms by
which a gammaherpesvirus spreads between cells during the
colonization of its natural host. Here, we have addressed the
role of the MHV-68 gM in viral lytic replication.
MATERIALS AND METHODS
Cell lines BHK-21 cells (American Type Culture Collection [ATCC] CCL-10),
NIH-3T3 cells (ATCC CRL-1658), NIH-3T3-CRE cells (6), 293T cells (ATCC
CRL-11268), NS0 cells (ATCC CRL-11177), and murine embryonic fibroblasts
(MEFs), harvested at 13 to 14 days of gestation, were grown in Dulbecco’s
modified Eagle medium (Invitrogen, Paisley, United Kingdom) supplemented
with 2 mM glutamine, 100 U of penicillin/ml, 100 g of streptomycin/ml, and
10% fetal calf serum (PAA Laboratories, Linz, Austria) (complete medium).
Medium for MEFs was further supplemented with 50 M -mercaptoethanol.
Where indicated, cells were transfected using Fugene-6 (Roche Diagnostics Ltd.,
Lewes, United Kingdom) according to the manufacturer’s instructions.
Plasmids. The MHV-68 ORF39 (genomic coordinates 56950 through 55799)
and ORF53 (genomic coordinates 71701 through 71444) were amplified by PCR
(Hi-Fidelity; Roche Diagnostics), including EcoRI and XhoI restriction sites in
the respective 5 and 3 primers. The PCR products were cloned into the EcoRI
and XhoI sites of pMSCV-IRES-NEO and pMSCV-IRES-ZEO (3). To make
NIH-3T3-gM/gN cells, each retroviral expression plasmid was cotransfected into
293T cells with the pEQPAM3 packaging plasmid (22). Supernatants were har-
vested 48 and 72 h posttransfection and used to transduce NIH-3T3 cells in the
presence of 6 g of hexadimethrine bromide (Sigma Chemical Co., Poole,
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FIG. 1. Characterization of the MHV-68 gM/gN complex. (A) BHK-21 cells were transfected with gN, gM, or gM plus gN or left untransfected.
All cells were then stained with 3F7 MAb and Alexa 594-coupled goat anti-mouse IgG PAb. Three representative transfected cells are seen in the
gMgN panel. No staining was seen with gM or gN alone. (B) Uninfected (solid lines) or MHV-68-infected (dotted lines, 3 PFU/cell, 18 h)
BHK-21 cells were stained with secondary antibody alone (control) or with MAb 3F7 plus FITC-conjugated rabbit anti-mouse IgG PAb. Samples
were analyzed by flow cytometry. These cells were not fixed or permeabilized, so staining was restricted to epitopes accessible at the cell surface,
presumably on virions. (C) NIH-3T3 cells stably transduced with retroviral vectors expressing gM and gN (3T3-gM/gN), uninfected BHK-21 cells,
and MHV-68-infected BHK-21 cells (2 PFU/cell, 18 h) were each fixed with methanol, permeabilized with 0.1% Tween 20, and stained either with
MAb 3F7 or with the isotype-matched, gB-specific MAb T7H9. Detection was done with Alexa 594-coupled goat anti-mouse IgG PAb. 3T3-gM/gN
cells showed only a discrete perinuclear cap of 3F7 staining. The equivalent perinuclear cap of staining in MHV-68-infected BHK-21 cells is
indicated by an arrowhead. (D) 3T3-gM/gN cells were stained with MAb 3F7 (red) and counterstained with DRAQ-5 (blue) to show the
perinuclear distribution of gM/gN. (E) MHV-68 virions (inf) were purified from the supernatants of MHV-68-infected BHK-21 cells by
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United Kingdom)/ml as previously described (26). Transduced cells were se-
lected with 1 mg of G418/ml plus 600 g of Zeocin (Invitrogen)/ml.
Viral mutagenesis. The MHV-68 gM coding sequence occupies genomic co-
ordinates 56950 through 55799 (28). We generated a gM-mutant MHV-68 bac-
terial artificial chromosome (BAC) by inserting an oligonucleotide with multiple
stop codons and a diagnostic EcoRI restriction site (5-CTAGCTAGCTAGAA
TTCTAGCTAGCTAG-3) into a PmlI restriction site at genomic coordinate
56407. The oligonucleotide was first cloned into BamHI genomic clone covering
genomic coordinates 49938 through 59884 in pUC9 (9). The vector was digested
with PmlI and dephosphorylated with Pandalus borealis alkaline phosphatase
(Roche Diagnostics). The oligonucleotide was denatured at 95°C, annealed to
itself at 37°C, and phosphorylated with polynucleotide kinase (New England
Biolabs, Hitchin, United Kingdom). The vector and oligonucleotide were then
joined with T4 DNA ligase (New England Biolabs). A BamHI-SacI fragment
incorporating the disrupted ORF39 (genomic coordinates 54271 through 59884)
was subcloned into the pST76K-SR shuttle plasmid, and the oligonucleotide
insertion was recombined from pST76K-SR into the MHV-68 BAC in DH10B
Escherichia coli by using transient RecA expression as previously described (1).
A revertant BAC was made by replacing the mutant ORF39 with an intact copy
in a similar way. Mutant and wild-type BACs were distinguished by the loss of the
PmlI restriction site and the gain of an EcoRI restriction site.
An MHV-68 intergenic expression cassette was constructed in pSP73 (Pro-
mega Corporation, Southampton, United Kingdom). First, an SphI fragment
containing the bovine growth hormone polyadenylation signal was subcloned
from pcDNA3 (Invitrogen) into the SphI site of pSP73 (pSP73-polyA). The M3
promoter (genomic coordinates 7281 through 7780) was then amplified by PCR
from MHV-68 genomic DNA, including BglII and EcoRI restriction sites in the
respective upstream and downstream primers. This was cloned into the BglII and
EcoRI sites of pSP73-polyA (pSP73-proM3-polyA). We then PCR-cloned the
gM coding sequence as an EcoRI-XhoI fragment (see paragraph on plasmids,
above) and ligated it into the EcoRI and SalI sites of pSP73-proM3-polyA. The
enhanced green fluorescent protein (eGFP) coding sequence was separately
cloned into the same sites in a similar way. Each expression cassette was then
excised from pSP73 with BglII and XhoI and blunted with Klenow fragment
DNA polymerase (New England Biolabs). In order to generate suitable recom-
bination flanks for the expression cassette, we subcloned a BglII genomic frag-
ment of MHV-68 (coordinates 75338 through 78717) from an EcoRI-HinDIII
genomic clone (9), ligating it into the BglII site of an otherwise unmodified
pSP73 vector. This construct was then cut at the MfeI site between the polyad-
enylation signals of ORF57 and ORF58 (genomic coordinate 77176), blunted
with Klenow fragment DNA polymerase, and dephosphorylated. We ligated the
blunt-ended expression cassette into the blunted MfeI site. The expression cas-
sette plus flanks was then subcloned as a BglII fragment into pST76K-SR and
recombined into the MHV-68 BAC as above. All BACs were reconstituted into
infectious virus by transfecting BAC DNA into BHK-21 cells as previously
described (7).
Virus growth and titration. BAC viruses were grown in BHK-21 cells and
titered by plaque assay on MEFs (7). Where indicated, the loxP-flanked BAC/
GFP cassette was removed from viruses by passing it through NIH-3T3-CRE
cells. All virus stocks were then prepared in BHK-21 cells. Infected cells and
supernatants were sonicated after harvesting. Cell debris was pelleted by low-
speed centrifugation (1,000  g, 3 min) and discarded. Virions were then pel-
leted by high-speed centrifugation (38,000  g, 90 min) and stored at 70°C. To
prepare MHV-68 virions, the virus pelleted from supernatants was resuspended
in phosphate-buffered saline (PBS), sonicated, layered over 5 to 15% Ficoll
gradients, and centrifuged again (30,000  g, 90 min). Virions were recovered as
a distinct band, resuspended in PBS, pelleted (30,000  g, 90 min), sonicated,
and stored at 70°C.
Southern blotting. DNA was extracted from virions by alkaline lysis, phenol-
chloroform extraction, and salt-ethanol precipitation as previously described (7).
Following restriction enzyme digestion, samples were electrophoresed on 0.8%
agarose gels and transferred to positively charged nylon membranes (Roche
Diagnostics). A [32P]dCTP-labeled probe (APBiotech, Little Chalfont, United
Kingdom) was generated by random primer extension (Nonaprimer kit; Qbio-
gene, Bingham, United Kingdom) according to the manufacturer’s instructions.
Membranes were hybridized with probe (65°C, 18 h), washed to a stringency of
0.2 SSC (1 SSC is 0.15 M NaCl plus 0.015 M sodium citrate)–0.1% sodium
dodecyl sulfate (SDS) at 65°C, and exposed to X-ray film.
Immunoblotting and immunoprecipitation. Monoclonal antibodies (MAbs)
specific for the MHV-68 gM/gN complex were generated according to estab-
lished protocols (16) by using an NS0 fusion partner and spleen cells of mice
previously infected with ORF73-deficient MHV-68 (11). For immune precipita-
tion, MHV-68-infected cells (5 PFU/cell, 18 h) were labeled for 15 min with
[35S]cysteine-methionine (PerkinElmer Life Sciences, Cambridge, United King-
dom) and chased for 4 h with 1 mM unlabeled cysteine-methionine as previously
described (3). Labeled cells were lysed on ice for 30 min in 1% Triton X-100–50
mM TrisCl (pH 7.4)–150 mM NaCl–5 mM EDTA with 1 mM phenylmethylsul-
fonyl fluoride and Complete protease inhibitors (Roche Diagnostics). Insoluble
debris was removed by centrifugation (13,000 g, 15 min). Lysates cleared of cell
debris were then further cleared by incubation with protein A-Sepharose (AP
Biotech). After removing the protein A-Sepharose, specific immune precipita-
tions were performed with MAb 3F7, the gH/L-specific MAb T4C5, or the
ORF4-specific MAb T3B8, each followed by further protein A-Sepharose.
Sepharose beads with bound antibody were washed five times in lysis buffer.
Samples were then dissociated (50°C, 15 min) in Laemmli’s buffer, resolved by
SDS-polyacrylamide gel elecrtrophoresis (PAGE), and exposed to X-ray film.
For immunoblotting, virus stocks or purified virions were lysed directly in Lae-
mmli’s buffer, heated (50°C, 15 min) with or without 2-mercaptoethanol, and
resolved by Tris-Tricine SDS-PAGE (24). The size-resolved proteins were trans-
ferred to polyvinylidene difluoride membranes (Perbio Science, Tattenhall,
United Kingdom) and immunoblotted with either the 3F7 MAb or the gB-
specific MAb T7H9, followed by horseradish peroxidase-conjugated rabbit anti-
mouse immunoglobulin G (IgG; Dako Corporation, Ely, United Kingdom).
Development was done with enhanced chemiluminescence reagents (AP Bio-
tech).
Immunofluorescence. Cells were washed in PBS, fixed in methanol (20°C, 5
min), and blocked for 30 min in PBS–10% fetal calf serum–0.1% Tween. For
monoclonal antibody staining, hybridoma supernatants were diluted 1/2 in PBS–
0.1% Tween and incubated with cells for 1 h at 4°C. Detection was carried out
with Alexa 594-coupled goat anti-mouse IgG (1 h, 4°C). Cells were washed three
times in PBS–0.1% Tween 20 after each antibody incubation. In some experi-
ments, nuclei were counterstained with DRAQ5 (Alexis Corporation, San Diego,
Calif.). Fluorescence was visualized on a Leica confocal microscope. For GFP
detection, unfixed cells were visualized under UV excitation on an Olympus
microscope, and images were captured with a Hamamatsu digital camera.
Flow cytometry. Cells infected with GFP viruses were washed in PBS and
analyzed directly for green channel fluorescence. For specific staining, cells were
incubated for 30 min on ice for 1 h with MAb 3F7, washed two times, and
incubated with fluorescein isothiocyanate (FITC)-conjugated rabbit anti-mouse
IgG polyclonal antibody (PAb; Dako Corporation). After washing two times,
cells were analyzed on FACSCalibur using Cellquest software (Becton-Dickin-
son, Oxford, United Kingdom). Graphs were plotted with FCSPress version 1.3
(http://www.fcspress.com).
RESULTS AND DISCUSSION
Characterization of MHV-68 gM and gN. Since there is little
information available on MHV-68 gM, we first undertook a
preliminary characterization of this protein and its likely bind-
ing partner, gN. The MHV-68 gM homolog is encoded by
ultracentrifugation on Ficoll density gradients. Lysates of uninfected BHK-21 cells (UI) were used as a control. All samples were denatured (50°C,
15 min) in Laemmli’s buffer with (reduced) or without (unreduced) 2-mercaptoethanol. Samples were resolved by Tris-Tricine SDS-PAGE,
transferred to polyvinylidene difluoride membranes, and immunoblotted with MAb 3F7. (F) BHK-21 cells were infected with MHV-68 (5 PFU/cell,
18 h) and then labeled for 1 h with [35S]cysteine-methionine. We immunoprecipitated gM/gN with MAb 3F7. For comparison, we immunopre-
cipitated gH/gL with MAb T4C5. Immunoprecipitates were dissociated at 95°C, treated () or not () with endoglycosidase H (EndoH), and
resolved by Tris-Tricine SDS-PAGE. Bands corresponding to gH and gN are indicated by arrowheads. (G) BHK-21 cells were infected with
MHV-68 (5 PFU/cell, 18 h) and then pulse labeled (P, 15 min) with [35S]cysteine-methionine followed by a 4-h chase (C) with excess unlabeled
cysteine-methionine. gM/gN was precipitated with MAb 3F7. For comparison, we immunoprecipitated from the same cells gH/gL with MAb T4C5
and ORF4 with MAb T3B8. Immunoprecipitates were dissociated at 50°C and resolved by SDS-PAGE.
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ORF39; its gN homolog is encoded by ORF53. We identified
a gM/gN-specific monoclonal antibody (MAb 3F7) in a panel
of MHV-68-specific monoclonal antibodies by immune fluo-
rescence of BHK-21 fibroblasts cotransfected with ORF39 and
ORF53 (Fig. 1A). Both genes were required for detectable
protein expression, suggesting that the epitope-bearing protein
was unstable in the absence of its binding partner. When both
gM and gN were present, the transfected cells showed perinu-
clear staining with the 3F7 MAb, which was therefore specific
for either a gN-dependent gM epitope or a gM-dependent gN
epitope.
Flow cytometry (Fig. 1B) established that the 3F7 epitope
was present on the surfaces of MHV-68-infected fibroblasts.
Immune fluorescence (Fig. 1C) of permeabilized, infected cells
with the 3F7 MAb showed staining in a well-defined perinu-
clear cap and at the plasma membrane. Fibroblasts stably ex-
pressing recombinant gM and gN (Fig. 1C and D) showed a
much more restricted staining pattern, with the 3F7 epitope
expressed only in a well-defined perinuclear cap. This was
consistent with gM/gN localization to Golgi membranes, a pat-
tern typical of gM/gN expression outside the context of viral
infection (20; C. Crump, personal communication). The more
restricted staining in Fig. 1C compared to Fig. 1A probably
reflects lower expression levels in stable cell lines. Surface
staining was not observed by flow cytometry of either BHK-21
cells cotransfected with gM and gN or of NIH-3T3 cells stably
transduced with retroviral vectors expressing gM and gN (data
not shown). The cell surface staining seen after MHV-68 in-
fection was therefore likely to be due to gM and gN being
incorporated into virions and then exported to the cell surface.
It is also possible that gM/gN heterodimers were indepen-
dently exported to the cell surface when another viral protein
was expressed.
We used immunoblots to distinguish whether the 3F7 MAb
recognized gM or gN (Fig. 1E). The predicted sizes of ungly-
cosylated gM and gN are 44 and 7 kDa (after signal peptide
cleavage), respectively. The 3F7 MAb detected an 8-kDa band
in reduced lysates of purified virions and was therefore specific
for gN. Immunoblots of unreduced virion lysates identified not
only the 8-kDa band but also higher-molecular-mass bands,
with the predominant one at 40 kDa. It therefore seemed likely
that, as in other herpesviruses, the MHV-68 gN is disulphide
linked to gM and both proteins are incorporated into virions.
The 10- to 20-kDa bands detected with MAb 3F7 in unreduced
virion lysates may be gN oligomers.
It was just possible to discern an 8-kDa band corresponding
to gN by immunoprecipitation with the 3F7 MAb from virus-
infected cells (Fig. 1F). When immunoprecipitates were disso-
ciated at 50°C rather than 95°C prior to loading, we could also
identify a 35-kDa protein precipitated by MAb 3F7 from pulse-
labeled cells (Fig. 1G), which was likely to be gM. After a 4-h
chase, there were both a smaller (33-kDa) band, suggestive of
FIG. 2. Disruption of ORF39 in the MHV-68 BAC. (A) We generated a gM-deficient MHV-68 BAC by inserting an oligonucleotide with
multiple stop codons and an internal EcoRI restriction site into a PmlI restriction site midway through ORF39. (B) BAC DNA was digested with
EcoRI, electrophoresed, transferred to nylon membranes, and probed with a BamHI-SacI genomic fragment as indicated in panel A. The predicted
bands were 9,215 bp for the wild type (WT) and revertant (REV) and 4,343 and 4,872 bp for the gM mutant (gM). (C) The same samples were
digested with PmlI. Because the oligonucleotide insertion disrupted the PmlI site at genomic coordinate 56407, the predicted band for the mutant
BAC was 11,420 bp, with 7,542 and 3,878 bp for the wild type and revertant.
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protein cleavage, and more diffuse bands in the 40- to 45-kDa
range, suggestive of glycan modification. Why it was smaller
than the predicted molecular mass of 44 kDa is not clear. The
35-kDa protein was prone to aggregation after denaturation,
since it entered SDS-PAGE gels after heating to 50°C but not
after boiling, consistent with the highly hydrophobic nature of
gM.
A targeted disruption of ORF39. In order to disrupt ORF39
(genomic coordinates 56950 through 55799), we inserted an
oligonucleotide with multiple stop codons in all reading frames
into a PmlI restriction site at genomic coordinate 56407. (Fig.
2A). Southern blots confirmed the predicted genomic structure
of the mutant BAC and its revertant (Fig. 2B and C).
These BACs were then transfected into BHK-21 cells. Virus
reconstituted from the wild-type and revertant BACs multi-
plied rapidly, whereas no infectivity was recovered from cells
transfected with gM-negative BACs (Fig. 3A). Because the
MHV-68 BAC cassette includes eGFP expressed from a hu-
man cytomegalovirus IE1 promoter (1), fibroblasts transfected
with BAC DNA or infected with virus containing the BAC
cassette show green fluorescence. By 3 days after transfection,
green fluorescence had spread to all cells in cultures trans-
fected with wild-type or revertant BACs. Single green fluores-
cent cells were also observed after transfection with ORF39-
disrupted BACs, but there was no spread to neighboring cells,
consistent with the lack of recoverable infectivity. eGFP cells
had disintegrated by 4 days after transfection (Fig. 3B) and
were lost completely from cultures upon further passage. The
same pattern was observed with three independently derived
ORF39-disrupted BAC mutants, in multiple transfections, and
in NIH-3T3 cells as well as BHK-21 cells. Thus, MHV-68
unable to express gM completely failed to spread.
Cells transfected with gM-negative BACs showed evidence
of viral protein synthesis in that they could be stained with an
MHV-68-specific immune serum (Fig. 3C) or with a gH/gL-
specific MAb (data not shown). However, they showed no
staining with the 3F7 MAb. This implied that virus-expressed
gN was unstable in the absence of gM or that expression of the
3F7 gN epitope was gM dependent, in agreement with the
results of transfections with gN and gM expression plasmids
(Fig. 1A).
Rescue of the gM-deficient phenotype by repair of ORF39.
We then tested whether complementation in trans could res-
cue the gM-deficient BACs. Thus, we cotransfected BHK-21
cells with a gM-negative BAC and a gM expression plasmid.
This led to spreading green fluorescence in the transfected
cells (data not shown), but a proportion of the virus recovered
also spread without further complementation, suggesting that
homologous recombination had restored ORF39 in the viral
genome and thereby generated revertant viruses (Fig. 4A).
This was confirmed by PCR analysis of DNA recovered from
infectious clones isolated by limiting dilution: all showed evi-
dence of an intact ORF39 (Fig. 4B). DNA sequence analysis of
PCR products from three clones confirmed the presence of
wild-type ORF39 (data not shown). Southern blots of the same
DNA samples showed three distinct patterns (Fig. 4C). These
were explained by the expression plasmid integrating into the
MHV-68 genome by a single crossover in ORF39, either 5 or
3 of the inserted oligonucleotide, and then resolving this in-
termediate to restore the native gM locus.
FIG. 3. Disrupting gM completely abolishes MHV-68 lytic spread.
(A) BHK-21 cells were transfected with 5 g of BAC DNA. Superna-
tants were harvested for infectious virus after transfection as indicated
and titered by plaque assay. gM1, gM2, and gM3 are three inde-
pendently derived BAC mutants. (B) The spread of infection from
transfected cells was also assayed by the expression of eGFP, which is
transcribed from a human cytomegalovirus IE1 promoter as part of the
MHV-68 BAC cassette (1). Representative areas of cultures 4 days
after transfection are shown as reverse images such that dark areas in
the picture correspond to green fluorescence. By this time, cells trans-
fected with ORF39-disrupted BACs had become fragmented, while the
surrounding cells appeared entirely normal. Nil, cotransfected. (C) At
24 h after transfection, cells were costained for MHV-68 antigens with an
immune rabbit serum and for gN with MAb 3F7 by using FITC-coupled
goat anti-mouse IgG and Alexa 594-coupled goat anti-rabbit IgG PAbs
for detection. To control for the possible effects of viral spread, we com-
pared the gM-disrupted BAC with a gH-disrupted BAC, which also failed
to generate infectious virus (J. S. May and P. G. Stevenson, unpublished
data). Representative transfected cells are shown.
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Clones 1, 4, 7, and 8 (crossover 5 of the oligonucleotide
insertion [Fig. 4A, pattern b]) showed only a small amount of
the 9.2-kb wild-type band. Plasmid insertion downstream of an
intact ORF39 was therefore a relatively stable arrangement,
without strong selection for a second recombination event. In
contrast, clones 10 through 16 (clone 11 was mixed) contained
significant amounts of the 9.2-kb wild-type band. The 4.8-kb
band in these clones was consistent with recombination be-
tween the retroviral and BAC ORF39 copies 3 of the oligonu-
cleotide insertion (Fig. 4A, pattern a). However, a 7.2-kb band
corresponding to the retroviral plasmid plus the 3 half of the
mutant ORF39 was never observed. Instead, there was a 12-kb
band, consistent with repair of the oligonucleotide insertion in the
upstream copy of gM. This suggested that either the retroviral
promoter was inadequate to drive gM expression or the oligonu-
cleotide insertion in the middle of gM compromised a function to
the right of ORF39 in the viral genome. After homologous re-
combination 5 of the oligonucleotide insertion, there was clearly
strong selective pressure for a second recombination event to give
a wild-type ORF39 locus (clones 2, 3, 5, 6, and 9).
Rescue of the gM-deficient phenotype by ectopic gM expres-
sion. The rescue of gM-deficient BACs by homologous recom-
bination with plasmid-based gM confirmed that disruption of
the gM locus was responsible for the nonviability of the gM-
mutant BACs. However, because complementation involved
plasmid integration and integration of plasmid 5 of the intact
gM copy was unstable, we could not be sure that gM itself was
the crucial function, rather than an overlapping function, such
as an ORF40 promoter. In order to link definitively the non-
viable virus phenotype to gM expression, we rescued the
ORF39-deficient BAC by expressing ORF39 from an ectopic
site in the viral genome.
FIG. 4. Restoration of infectivity during complementation correlates with the repair of ORF39. (A) Virus recovered from BHK-21 cells
cotransfected with ORF39-disrupted BACs and a retroviral gM expression plasmid were cloned by limiting dilution. There was the potential for
gM to be reconstituted by recombination between BAC and expression plasmid DNA either 3 (pattern a) or 5 (pattern b) of the oligonucleotide
insertion, thereby integrating the expression plasmid into the BAC. There could then be further recombination between the gM copies to excise
the plasmid sequence and reconstitute the wild-type (WT) genome. (B) ORF39 was amplified by PCR of BAC DNA (gM1, gM2, WT, REV)
or of DNA from the infectious viral clones recovered after cotransfection (R1 through R5). PCR products were then digested () or not () with
EcoRI. Digestion of the 1,150-bp gM band into 608- and 543-bp fragments indicated the presence of the inserted oligonucleotide. The proportions
of mutant and intact ORF39 cannot be compared, since the oligonucleotide insertion may have reduced the efficiency of PCR amplification. The
key point is that appreciable amounts of wild-type viral DNA were always present in infectious viral clones. (C) Viral DNA was digested with
EcoRI, electrophoresed, blotted, and probed with a labeled BamHI genomic clone as indicated for panel A. The numbers 1 through 16 refer to
individual infectious virus clones recovered after cotransfection. The 1,167- and 1,342-bp fragments were unaffected by gM reconstitution. A 5
crossover in ORF39 to integrate the expression plasmid (1,150 bp of ORF39 plus 6.5 kb of plasmid) should have given 4,343-, 543-, and 11,980-bp
fragments. A 3 crossover in ORF39 should have given 4,886-, 7,108-, and 4,872-bp fragments. The latter pattern was never seen complete,
indicating that there was selective pressure to lose the EcoRI site from the right-hand copy of ORF39. A double crossover to excise all plasmid
sequences gave the 9,215-bp wild-type band that was present to some degree in all samples.
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We first established a viable intergenic expression system for
MHV-68 by using the intergenic region between ORF57 and
ORF58 (Fig. 5A). ORFs 57 and 58 meet at their 3 ends, so the
intervening sequence is unlikely to contain crucial viral pro-
moter functions; the equivalent intergenic region in KSHV
contains multiple vIRF genes (23). As a strong lytic promoter,
we used the 500 bp upstream of the transcriptional start site of
the MHV-68 M3, an abundant early-late lytic gene (27). Pre-
liminary experiments using eGFP expression from the M3 pro-
moter region established that the ORF57/ORF58 intergenic
expression cassette was actively transcribed in lytically infected
cells (Fig. 5B). We then generated an equivalent gM expres-
sion cassette and recombined it into the gM-deficient BAC.
This restored viral viability, and the gM rescue virus propa-
gated efficiently after the transfection of BAC DNA into
BHK-21 cells.
Southern blots of viral DNA confirmed the predicted
genomic structure of the gM rescue virus but also showed a
small proportion of wild-type DNA in the complemented virus
stocks (Fig. 5C and D). There was no sign of wild-type ge-
nomes in digests of the gM rescue BAC DNA (data not
shown), so the appearance of wild-type DNA presumably re-
flected a double recombination between the inserted and en-
dogenous copies of ORF39, restoring an intact ORF39 to its
FIG. 5. Rescue of the ORF39-deficient BAC by intergenic ORF39 expression. (A) An intergenic expression cassette, designed to transcribe gM
from an ectopic viral M3 promoter, was recombined into the gM mutant MHV-68 BAC between ORF57 and ORF58. (B) An equivalent intergenic
eGFP expression cassette (57/M3-GFP/58) showed strong green fluorescence in lytically infected BHK-21 cells (0.5 PFU/cell, 18 h) by flow
cytometry. The BAC cassette had been removed from this virus, so eGFP expression was driven solely by the ectopic M3 promoter. This established
that the intergenic expression cassette was functional. (C) Southern blots of the rescued gM mutant virus (RES) showed with PmlI digestion a
11,420-bp band due to loss of the PmlI site in ORF39 (open arrowhead). However, there was also a low level of the 7,542- and 3,878-bp wild-type
(WT) bands (black arrowheads). Hybridization of the probe to the intergenic ORF39 expression cassette gave the predicted bands of 1,254 and
3,337 bp (gray arrowheads). These were weaker due to less overlap with the probe. (D) EcoRI digestion also showed evidence of some wild-type
DNA (9,215-bp band) (black arrowhead). The 4,343- and 4,872-bp bands seen with the rescued virus correspond to the oligonucleotide insertion
(open arrowheads). There was also a 4,862-bp band (gray arrowhead) which ran as a doublet with the 4,872-bp band, corresponding to the
intergenic ORF39 expression cassette. (E) All clones of the rescued viruses (R1 through R8) showed an pattern identical to that of the parent.
The rescued pattern (11,420 bp) was always dominant, but each clone also showed a low level of wild-type ORF39 (7,542 and 3,878 bp). The
proportion of wild-type DNA appeared to be constant. The open arrowhead shows the gM mutant band, the black arrowheads show wild-type
bands, and the gray arrowheads show intergenic expression cassette bands.
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normal site. Recombination could not occur within a single
viral genome without deleting an essential central region but
could potentially occur between genomes. We then cloned this
mixed-virus stock by limiting dilution to remove any contami-
nating wild-type virus. However, all clones of the mixed virus
showed the same pattern of low-level wild-type DNA (Fig. 5E).
There was no obvious change in the overall proportion of
wild-type DNA with passage, and no wild-type—or even pre-
dominantly wild-type—clones were identified.
This was very different to the pattern of clones obtained
after recombination of the gM expression plasmid into the viral
genome (Fig. 4C). There, there was strong selective pressure
for the flank 5 of gM to be repaired. With intergenic gM
expression, recombination to repair the endogenous gM locus
did not appear to confer a significant increase in viral fitness,
since there was no evidence of selection for wild-type virus with
passage. Thus, the M3 promoter, unlike the integrated retro-
viral promoter, expressed sufficient gM to rescue the mutant
virus.
Growth curves (Fig. 6A) established that the complemented
virus grew comparably to wild-type virus. Thus, there was res-
cue from complete nonviability to wild-type levels of lytic rep-
lication. It was formally possible that the normal growth of the
gM rescue virus was due to a small proportion of replication-
competent wild-type genomes in otherwise replication-defec-
tive virus stocks, with stock titers measuring only the wild-type
virus. This would predict considerably more viral protein for a
given plaque titer in stocks of the gM rescue virus. However,
despite wild-type DNA being 10% of total viral DNA in gM
rescue virus stocks (Fig. 5), the gB content of stocks was equiv-
alent between wild-type and gM rescue viruses (Fig. 6B). More
gN was present in the wild-type stocks, presumably reflecting
that gM rescue still gave suboptimal reconstitution of the
gM/gN heterodimer, but this appeared to be tolerated. The
intergenic expression cassette was therefore responsible for
restoring viral fitness, establishing that gM expression was the
essential viral function compromised by the oligonucleotide
insertion.
Some complementation of the gM-disrupted BAC was also
possible by transfecting BAC DNA into the NIH-3T3 cells
stably expressing gM and gN (Fig. 6C). In contrast to the single
eGFP cells seen after the transfection of unmodified fibro-
blasts (Fig. 3B), there was a definite spread of eGFP expres-
sion between adjacent gM and gN fibroblasts. Further pas-
sage of these cultures on BHK-21 cells showed no evidence of
recombination between cellular and viral gM to generate re-
vertant viruses (data not shown). This complementation by
cellular gM/gN expression therefore supported further the idea
that gM expression was the crucial viral function lost with
oligonucleotide insertion into ORF39. The fact that the only
limited complementation was achieved—viral titers remained
very low—implied that cellular gM/gN expression was well
below optimal levels for viral replication. This was not surpris-
ing, since MHV-68 causes host shutoff (25) and the accumu-
lation of gN/gM in NIH-3T3-gM/gN cells was always well be-
low that seen in infected fibroblasts (Fig. 1). The key point is
that some viability was restored to the gM-deficient BAC.
In conclusion, gM was found to be essential for MHV-68
lytic replication in fibroblasts. Multiple, independently derived
BACs with an oligonucleotide inserted into ORF39 were com-
FIG. 6. Replication of complemented ORF39 mutant virus.
(A) BHK-21 cell monolayers were infected with either wild-type or gM
rescue viruses as indicated. Viral titers with time were measured by plaque
assay. (B) Virus stocks were lysed in Laemmli’s buffer and analyzed for
viral protein content by SDS-PAGE and immunoblotting for gB and gN.
The number of viral PFU equivalents in each lane is indicated. The two
main bands for gB represent the 120-kDa full-length protein and a 65-
kDa C-terminal cleavage product; each exists as two or three different
glycoforms. (C) Examples of the spread of GFP expression observed
after the transfection of gM-disrupted BAC DNA into 3T3-gM/gN
cells, with groups of 5 to 10 GFP cells, are shown. Figure 3B shows
equivalent BACs transfected into noncomplementing BHK-21 cells.
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pletely replication defective, and this phenotype could be res-
cued by reversion of the BAC, repair of ORF39, or ectopic gM
expression from the viral genome or from cellular DNA. The
absolute requirement of MHV-68 for gM contrasted markedly
with herpes simplex virus and pseudorabies virus, in which gM
is inessential, but was consistent with an essential role for gM
in human cytomegalovirus. The function of the MHV-68
gM/gN remains unknown. However, the evidence from other
viruses suggests that a role in secondary envelopment is likely
(15, 17, 19). Whether this function of gM/gN is essential or not
presumably depends on whether other viral glycoproteins, such
as gE/gI in alphaherpesviruses, have evolved sufficient interac-
tion with tegument proteins to substitute for gM/gN (21). Al-
ternatively, gM/gN in MHV-68 may fulfil a further function
that is essential for viral lytic replication.
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